Neuraxis (AMEX: NRXS) reported quarterly losses of $(0.33) per share which missed the analyst consensus estimate of $(0.24) by 37.5 percent. This is a 3.13 percent decrease over losses of $(0.32) per share from the same period last year. The company reported quarterly sales of $895.65 thousand which missed the analyst consensus estimate of $725.00 million by 99.88 percent. This is a 38.51 percent increase over sales of $646.63 thousand the same period last year.